News

The Joint Corp. Achieves Significant Growth in 2024 Metrics

The Joint Corp. Achieves Significant Growth in 2024 Metrics

The Joint Corp. Showcases Remarkable Growth in 2024 Metrics

- Adjustments Performed in 2024 Grows 9%, Compared to 2023 -
- Receives Letters of Intent for Majority of Corporate Portfolio -

SCOTTSDALE, Ariz. — The Joint Corp. (NASDAQ: JYNT), a leader in chiropractic care across the nation, has reported impressive operating metrics for the year ending 2024. The company's efforts in enhancing patient experience and expanding its franchise network have positioned it well in a competitive marketplace.

2024 Full Year Operational Insights

Throughout 2024, The Joint Corp. has made significant strides, delivering operational highlights that underline its commitment to healthcare excellence:

  • Executed approximately 14.7 million patient visits, showing an increase from 13.6 million in the previous year.
  • Welcomed 957,000 new patients, up from 932,000 in 2023.
  • Achieved system-wide sales growth of 9%, although this is a decrease from 12% growth in 2023.
  • Maintained comparable sales growth at 4%, in line with the prior year.
  • Granted 46 new franchise licenses, a slight decrease from 55 in 2023.
  • Increased total clinic numbers to 967, up from 935 at the end of 2023.
    • Opened 57 new locations, refranchised 3, and closed 18 (including 3 relocations) maintaining a strong franchised clinic network.
    • Refranchised 3 and closed 7 clinics, allowing 125 company-owned or managed clinics to operate by year-end 2024, down from 135 in the previous year.

Leadership Insights

“Our focus on enhancing the patient experience has clearly paid off, with growth in patient numbers and franchise locations,” stated Sanjiv Razdan, President and CEO of The Joint Corp. “During my first 100 days with the company, I have had the pleasure of interacting with a diverse range of stakeholders and have collected invaluable insights to drive The Joint's evolution into a premier franchisor in 2025. We are thrilled by the letters of intent received in early January to refranchise the majority of our corporate clinic portfolio, marking a strategic move towards fulfilling our growth potential.”

Plans for Future Growth

Looking forward, The Joint Corp. intends to implement several initiatives aimed at continuing its momentum. In the first half of the upcoming year, the company plans to introduce considerate price adjustments, enhance promotional efforts, launch a mobile application, and adopt a more robust digital marketing approach to attract new patients and bolster retention.

Financial Reports on the Horizon

The company has announced that its fourth quarter and year-end financial results for 2024 will be disclosed on March 13, 2025, after market closure. This presentation will feature insights from President and CEO Sanjiv Razdan and CFO Jake Singleton during a conference call that evening.

Understanding The Joint Corporation's Business Model

The Joint Corp. revolutionized chiropractic care in 2010 by implementing an innovative retail healthcare model. It has since become a significant player in the industry, emphasizing quality care that is both convenient and affordable, thus catering to a broad audience devoid of insurance dependency.

With over 950 clinics nationwide and achieving more than 14 million patient visits annually, The Joint Chiropractic has solidified its reputation as a frontrunner in the chiropractic sector. It has been consistently recognized in various industry rankings, underscoring its solid standing in the franchise market.

Commitment to Excellence in Healthcare

As The Joint Corp. continues to grow, its dedication to improving patient access and operational efficiency remains paramount. The company has garnered numerous accolades for its franchising initiatives, reinforcing its status as a leader in the chiropractic care sector.

Frequently Asked Questions

What is The Joint Corp.'s primary business focus?

The Joint Corp. primarily operates, manages, and franchises chiropractic clinics across the nation.

How many patient visits did The Joint Corp. report in 2024?

In 2024, The Joint Corp. reported approximately 14.7 million patient visits.

What growth strategy is The Joint Corp. implementing moving forward?

The company plans to initiate price increases, enhance promotions, launch a mobile app, and improve digital marketing strategies.

When will The Joint Corp. report its 2024 financial results?

Financial results will be reported on March 13, 2025.

Is The Joint Corp. recognized in the franchising industry?

Yes, The Joint Corp. has received multiple accolades acknowledging its excellence in the franchising sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

STMicroelectronics Share Buyback Program: Key Details Uncovered

Updated Category News Views 167

Overview of STMicroelectronics’ Share Repurchase Program STMicroelectronics N.V., the renowned semiconductor giant, has recently provided a comprehensive update regarding its common share repurchase program. This strategic initiative, designed to enhance shareholder value, was initially disclosed in a previous announcement made in June 2024. With a shareholder...

Continue Reading
Penn Mutual Receives Recognition as a Top Employer in Finance

Updated Category News Views 52

Penn Mutual Recognized as One of the Best Workplaces Penn Mutual Life Insurance Company is thrilled to announce that it has been included in the coveted 2024 Fortune Best Workplaces in Financial Services & Insurance List. This honor marks the second time the company has earned a spot, showcasing its commitment to employee well-being and a strong workplace culture. How the...

Continue Reading
Innovative Hairstyling Clippers Revolutionizing Precision Cuts

Updated Category News Views 302

Revolutionizing Hair Cutting with the TRUE EDGE In a world where hairstyling requires both precision and efficiency, a new invention is set to change the way haircuts are delivered. An inventive mind from Texas has recognized that there could be a more effective method for achieving straight lines while cutting or edging hair. This insight led to the development of the...

Continue Reading
Tyler Technologies to Host Earnings Call: Key Details Inside

Updated Category News Views 96

Tyler Technologies Earnings Conference Call Scheduled Tyler Technologies, Inc. (NYSE: TYL) is making strides as it prepares for its third-quarter earnings results conference call. Scheduled for an upcoming Thursday, the call is set to take place at 10:00 a.m. ET and promises to be an informative session for stakeholders, investors, and industry enthusiasts alike....

Continue Reading
Auction Process for Government Bonds by Riksbank Explained

Updated Category News Views 232

Understanding the Riksbank Auction Process for Government Bonds The way Riksbank conducts auctions for government bonds plays a crucial role in determining monetary policies and financial strategies. These auctions allow investors to bid for bonds, which is essential for both investment opportunities and economic stability. Bid Procedure Details On the designated bid...

Continue Reading